QuikClot receives expanded CE Mark

Z-Medica®, LLC, a leading developer and marketer of hemostatic devices, announces today they have received an expanded CE Mark for their QuikClot® products in the European Union (EU). The expanded indication includes the use of the company’s kaolin-based hemostatic products for traumatic bleeding and in conjunction with anti-coagulant therapy. The indications for use in EU are now the same as they are for the U.S.: Military/EMS/LE products: Indicated for temporary external use to control traumatic bleeding. Hospital products: Indicated as a topical dressing for the local management of bleeding wounds such as cuts, lacerations, and abrasions. It may also be used for temporary treatment of sev


Cardiogenics Ltd, Robertson House, 49 Grange Avenue, Baldoyle Industrial Estate, Dublin, D13 H2N2   01-6978528